The Telangana High Court on 5 November held that a person who assigns patent rights through a duly executed written agreement ceases to be the patentee and cannot maintain an infringement suit, even if the assignment has not been registered with the Patent Office.

A Bench of Justices T. Vinod Kumar and Anil Kumar Jukanti allowed a revision petition filed by Cadila Healthcare Limited, now Zydus Lifesciences Limited, and rejected the plaint in a patent infringement suit instituted by Abburi Ramaiah.

The judges observed that the plaint contained “camouflaged statements” creating an “illusionary cause of action”.

Ramaiah had instituted the suit in 2017, alleging infringement of Patent No. 239632 and seeking a permanent injunction and damages of Rs. 1 crore. Cadila sought rejection of the plaint, contending that Ramaiah had assigned the patent to Samastha Laboratories Private Limited through a deed dated 12 April 2014 and, therefore, lacked locus standi to institute the suit.

Opposing the application, Ramaiah argued that the assignment was still pending before the Patent Office and that he continued to qualify as the patentee. The Commercial Court at Hyderabad accepted his contention, holding that the assignment had not been formally recorded when the suit was instituted.

The High Court disagreed, relying on Section 68 of the Patents Act, which, following its amendment in 2005, no longer requires registration of an assignment for it to take effect. It held that an assignment becomes effective once the agreement embodying its terms is reduced to writing and duly executed. It observed:

“The effect of omitting the requirement of 'registration' by Amendment Act, 2005 is that the original patentee ceases to be the registered patentee upon executing a valid assignment.”

Further, the Bench noted that the patent register reflected Samastha Laboratories as the patentee with effect from 16 April 2014. Ramaiah had neither specifically denied this assertion in his counter-affidavit nor produced documents to substantiate his claim that the assignment was still pending.

It held that Ramaiah lacked locus standi to institute the infringement suit, clarifying that Section 2(p) of the Act recognises as a 'patentee' either the original grantee who continues to hold the patent or a third party who acquires ownership through assignment. Both cannot simultaneously claim that status. It also noted that the patent had expired in 2024, ruling out any continuing infringement thereafter.

Accordingly, the High Court set aside the Commercial Court's order and rejected the plaint.

For Petitioner: Senior Counsel Avinash Desai with Advocate Shireen Sethna Baria

For Respondents: Senior Counsel Ramesh Babu Vishwanathula

Tags:    
Case Title :  Cadila Healthcare Limited (Now Zydus Lifesciences Limited) v. Mr. Abburi Ramaiah and anotherCase Number :  C.R.P.No.1623 OF 2026CITATION :  2026 LLBiz HC(TEL) 79